Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tobramycin én Gang Daglig Mot Tre Ganger Daglig, Gitt Med Benzylpenicillin, Til Pasienter Med nøytropen Feber

NCT00257790 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT00257790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00257790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tobramycin én Gang Daglig Mot Tre Ganger Daglig, Gitt Med Benzylpenicillin, Til Pasienter Med nøytropen Feber
Lead sponsor
Oslo University Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2001
Completion date
March 31, 2005
Enrollment
210
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, fever, neutropenia